Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement.
Resmed Inc. has announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the New York Stock Exchange closes. The announcement includes a webcast for discussing the results, which may impact stakeholders by providing insights into the company’s performance and strategic direction.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$37.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc. is a company dedicated to creating life-changing health technologies, focusing on AI-powered digital health solutions, cloud-connected devices, and intelligent software. Their products aim to make home healthcare more personalized, accessible, and effective, with a vision to enhance sleep and breathing health for people in 140 countries.
Average Trading Volume: 1,161,681
Technical Sentiment Signal: Buy
Current Market Cap: A$57.03B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.